Overview

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Status:
Withdrawn

Trial end date:
2023-10-01

Target enrollment:

Participant gender:

Summary

This is a Phase II treatment, randomized 3:1 ratio, open label clinical trial to study the effect of short duration administration of N-acetyl cysteine on oral microbiome and on mucositis caused by concurrent chemotherapy and radiotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Wake Forest University Health Sciences

Collaborator:

National Cancer Institute (NCI)

Treatments:

Acetylcysteine
N-monoacetylcystine